- Research article
- Open Access
ATP-induced autophagy is associated with rapid killing of intracellular mycobacteria within human monocytes/macrophages
© Biswas et al; licensee BioMed Central Ltd. 2008
- Received: 05 February 2008
- Accepted: 15 July 2008
- Published: 15 July 2008
We have previously reported that ATP treatment of M bovis-BCG infected human macrophages induces P2X7 receptor-dependent killing of intracellular mycobacteria. The mechanism mediating this bactericidal effect has not been full characterized but is known to be Ca2+-dependent and to promote the maturation and acidification of mycobacteria-containing phagosomes. In this study we demonstrate that the ATP/P2X7-mediated, mycobactericidal effect also involves the induction of cell autophagy.
We report that 3 mM ATP induces rapid cell autophagy in THP1 cells and monocyte-derived macrophages within 30 minutes post-treatment, as revealed by the expression of LC3-II bands on western blot analysis. Using Ca2+-free media and selective P2X7 agonists and antagonists, ATP-induced cell autophagy was shown to be Ca2+ and P2X7 receptor-dependent. Electron microscopy of ATP-treated, BCG-infected MDMs revealed the presence of the bacteria within characteristic double-membraned autophagosomes. Confocal analysis further confirmed that pharmacological inhibition of autophagy by wortmannin or pre-treatment of macrophages with anti-P2X7 antibody blocked ATP-induced phago-lysosomal fusion. Induction of cell autophagy with ATP was also temporally associated with a fall in intracellular mycobacterial viability, which was suppressed by treatment with wortmannin or the selective P2X7 antagonist, oxidized ATP (oATP).
We provide the first evidence that ATP/P2X7-mediated killing of intracellular mycobacteria involves the induction of cell autophagy. The findings support the hypothesis that autophagy plays a key role in the control of mycobacterial infections.
- THP1 Cell
- P2X7 Receptor
- Cell Autophagy
- Intracellular Mycobacterium
- P2X7 Agonist
Tuberculosis continues to be a leading cause of human mortality and morbidity, with WHO figures estimating a global prevalence exceeding 14 million and mortality of approximately 1.6 million in the year 2005 . The continuing global crisis has become further complicated by the emergence of multi-drug resistant strains of the bacteria and an increasing population of HIV-infected patients around the world. In view of this escalating clinical challenge, there is a growing need to develop novel therapeutic alternatives employing potent mycobactericidal mechanisms. Hence, there has been a lot of interest in cell autophagy as a potential immune defense mechanism against a number of bacterial pathogens, including mycobacteria [2–5]. Physiological or pharmacological induction of autophagy via cell starvation or treatment with rapamycin, have been reported to suppress mycobacterial survival within RAW cells through increased acidification and maturation of mycobacterial phagosomes .
It has been previously reported from our laboratory that treatment of infected human macrophages with adenosine 5'-triphosphate (ATP) was capable of killing mycobacteria by subverting the mycobacterium-induced block in phago-lysosomal fusion [6, 7]. In the light of recent findings, the present study was undertaken to look for evidence of induction of cell autophagy within ATP-treated macrophages and of a role for this process in mediating its associated mycobactericidal activity. In this work we demonstrate, for the first time, that ATP induces autophagy in human macrophages within 30 minutes of exposure, which was associated with a subsequent decrease in Mycobacterium bovis BCG viability within infected cells. We further confirmed a role for extracellular Ca2+ and delineated the identity of the purinergic receptor involved in this process by using Ca2+-free media and selective purinergic receptor agonists and antagonists. We were thus able to confirm that ATP induces rapid cell autophagy and killing of intracellular mycobacteria within infected human macrophages via a Ca2+-dependent process mediated by activation of P2X7 receptors. The results support the importance of autophagy as a mycobactericidal mechanism utilized by human macrophages and provide a possible rationale for the recently reported P2X7 polymorphisms associated with extra-pulmonary TB . The findings also suggest a potential therapeutic role for P2X7 agonists in treating mycobacterial infections.
ATP induces autophagy
To determine whether ATP was capable of inducing autophagy in THP1 cells and monocyte-derived macrophages (MDMs), the expression of the microtubule-associated (LC3-I) and membrane associated (LC3-II) forms of LC3 protein were assessed in both ATP-treated and untreated cells by Western Blot and Confocal microscopy.
ATP-induced autophagy is dependent on mobilization of extracellular calcium
We have previously reported that ATP can stimulate Ca2+ entry into cells not only through activation of ionotropic P2X purinoceptors, but also via mobilisation of intracellular Ca2+ into the cytosol by activation of metabotropic P2Y receptors . We then sought to establish the relative contribution of these Ca2+ sources to the induction of autophagy by examining the cellular response to ATP (3 mM) stimulation for 30 minutes in both Ca2+-containing and Ca2+-free medium. In cells treated with ATP in Ca2+-containing media we observed the induction of autophagy by Western blot analysis as revealed by the expression of both the 16 kDa and 18 kDa forms of LC3 protein (Figure 1C). In contrast, ATP-induced cell autophagy was shown to be completely inhibited in Ca2+-free medium, as revealed by the absence of expression of the 16 kDa lipidated form of LC3 (LC3-II) (Figure 1C).
ATP-induced autophagy is P2X7 – dependent
Having obtained preliminary evidence of P2X receptor involvement in ATP-induced cell autophagy from the above results, we sought evidence that this process involved P2X7 receptors. We then investigated the induction/inhibition of autophagy in response to a number of purinergic receptor agonists and antagonists. It was observed in Western blot assays (Figure 1D) that autophagy (LC3-II expression) was not induced following uridine 5'-triphosphate (UTP) (3 mM) stimulation, which activates P2Y, but not P2X receptors. In contrast, autophagy was induced by the ATP analogue, benzoylbenzoic ATP (bzATP), which selectively activates P2X7 receptors. To further confirm the role of the latter receptor, we pre-treated THP1 and MDM cells with either adenosine 5'- triphosphate periodate oxidized ATP (oATP); an irreversible antagonist of P2X7, or an anti-P2X7 blocking antibody, before treating with ATP. Autophagy was completely blocked in the presence of either inhibitor, as demonstrated by the absence of LC3-II expression in Western blot gels (Figure 1D), thereby confirming that ATP-induced autophagy is mediated via activation of P2X7 receptors.
ATP induced phago-lysosomal fusion in infected macrophages is autophagy- dependent
We have previously reported that ATP stimulation of P2X7 promotes acidification of BCG-containing phagosomes within infected human macrophages . Moreover, it has also been reported that induction of autophagy in RAW cells by starvation or treatment with rapamycin was associated with acidification and maturation of mycobacterial phagosomes . In view of these findings, we analyzed the role of autophagy in ATP-mediated phago-lysosomal fusion within MDMs infected with green fluorescent protein expressing M. bovis BCG (GFP-BCG). Lysosomal trafficking was monitored by preloading BCG-infected cells for 1 hour with the acidotropic fluorescent dye Lysotracker Red that accumulates within acidic organelles . The cells were then stimulated with ATP (3 mM) for 30 minutes. While control non-ATP treated cells showed minimal co-localisation of GFP-BCG with Lysotracker Red labeled lysosomes (7.2 ± 2.5%), there was significantly greater co-localisation within ATP-treated cells (63.3 ± 4.5%) (p < 0.01; student's unpaired t test) (Figures 2B &2C). The results confirmed our previously reported findings on the ability of ATP to induce phago-lysosomal fusion within BCG-infected MDMs . We next examined whether pharmacological inhibitors of autophagy could block this effect. We observed that wortmannin, a classical phospatidylinositol-3 kinase (PI3 Kinase) inhibitor, which has previously been reported to inhibit the early stages of autophagosome formation , dramatically reduced the levels of co-localisation of BCG-containing phagosomes with lysosomes (29.5 ± 3.8%) (p < 0.01; student's unpaired t test) (Figures 2B &2C). The results support the involvement of cell autophagy in ATP-induced, phagolysosome fusion and acidification of mycobacteria-containing phagosomes. Pre-treatment of MDMs with an anti-P2X7 neutralising antibody also resulted in a significant reduction in the levels of co-localisation (36.8 ± 5.4%) (p < 0.01; student's unpaired t test) (Figures 2B &2C).
Localization of mycobacteria in autophagosomes
ATP-induced autophagy mediates rapid mycobacterial killing
In this study we have shown that ATP-treated, BCG-infected THP-1 cells and MDMs undergo rapid cell autophagy, which involves the activation of P2X7 receptors and mobilization of extracellular calcium. Electron microscopy of ATP-treated, BCG-infected MDMs, revealed the presence of the bacteria within characteristic double-membraned autophagosomes. In addition, ATP-induced cell autophagy was accompanied by rapid phago-lysosomal fusion and loss of mycobacterial viability within infected cells suggesting that autophagy contributes to this mycobactericidal process.
Autophagy has recently been highlighted as an innate immune defense mechanism against bacterial pathogens such as Group A Streptococcus, Shigella and Mycobacterium tuberculosis [2–5]. Bacterial agents like Listeria monocytogenes and Staphylococcus aureus have also been reported to evade host immunity by subverting autophagy, thereby underscoring its importance as a potent mycobactericidal mechanism [12, 13]. Earlier studies in rat hepatocytes had shown an association between reduction in the volume density of autophagic vacuoles and a fall in intracellular ATP levels . In this study we sought to obtain more direct confirmation that extracellular ATP could induce autophagy in human macrophages. We demonstrated that LC3 lipidation and LC3-II association with autophagosomal membranes, which are both commonly used read-outs of autophagy [9, 10], were induced by ATP, as revealed by immunoblotting and the transition of LC3 from its diffuse cytosolic appearance to a punctate intracellular distribution (Figure 1A &1B, Figure 2A).
Exploring the identity of the purinergic receptor involved in the process, we observed that ATP-induced autophagy was mediated via activation of P2X7, as revealed by the use of specific agonists and antagonists of this receptor. Autophagy was not induced in the absence of extracellular calcium (Fig 1c), which was consistent with the known property of P2X7 to promote influx of extracellular calcium into the cytosol in contrast to P2Y, which mobilize intracellular calcium.
The highly polymorphic structure of P2X7 has recently been described and five polymorphisms have been described that lead to reduction or loss of P2X7 function . It has recently been shown that P2X7 polymorphisms were associated with impaired ATP-induced mycobacterial killing  and increased susceptibility to extra-pulmonary TB . The present study is the first to report on the involvement of P2X7 in inducing cell autophagy and provides a possible rationale for the impaired mycobactericidal activity and increased predilection for extra-pulmonary TB associated with certain polymorphic forms of P2X7.
Our laboratory and others have previously reported that elevation of cytosolic calcium levels in ATP-treated, BCG-infected macrophages is linked to increased phago-lysosomal fusion [7, 25]. Since induction of autophagy was dependent on mobilization of extracellular calcium, we explored its effect on maturation of mycobacterial phagosomes. Induction of autophagy by ATP coincided with increased acidification of mycobacterial phagosomes, which was reversed on pre-treatment of MDMs with wortmannin. In ATP-treated cells, the bacteria were found to localize within characteristic double-membraned autophagosomes. A difference in appearance and positioning of both lysostraker red labeled vesicles and GFP-BCG within wortmannin treated cells was observed as compared to anti-P2X7 and non-treated macrophages (Figure 2B). This was attributed to the previously reported effect of wortmannin to induce swelling of late endosomal compartments associated with PI3-K inhibition involved in membrane trafficking between late endosomes and lysosomes [26, 27]. We further observed that addition of ATP had a bactericidal effect on BCG, which was reversed partially by wortmannin and almost completely by oATP (Figure 4). These findings are consistent with recent observations by Gutierrez et al who demonstrated that induction of autophagy, by starvation or rapamycin, in macrophages infected with M. tuberculosis (Mtb), leads to maturation of mycobacteria-containing phagosomes into phagolysosomes and suppression of mycobacterial viability . Hence, induction of autophagy with ATP, as with the classical inducers like starvation or rapamycin, can override the mycobacterial block on phagosomal maturation. This ability of autophagy to induce phago-lysosomal fusion and subsequent bactericidal activity could have potential therapeutic implications. In view of the involvement of P2X7 receptors in this phenomenon, the development of selective, potent and safe P2X7 agonists as therapeutic alternatives in the treatment of multi drug resistant (MDR)-TB should be explored.
The bactericidal effect of ATP on BCG or Mtb in human and bovine MDMs has been reported previously by our laboratory and other groups [6, 17, 18], though the mechanism of such action has not been clearly elucidated. It has been recently shown that Mtb infection of macrophages leads to intracellular accumulation and extracellular release of ATP, which in turn activates P2X7 receptors to mediate cellular apoptosis and bacterial killing . Apoptosis was induced in this latter study in 26.5 ± 2.5% of macrophages in response to stimulation with 5 mM ATP at an MOI of 10:1, following 48 hours of infection . However, the evidence for ATP-induced apoptosis is still equivocal, as we have found that caspase inhibitors do not block ATP-mediated killing of intracellular mycobacteria although they do block IL-1β release . Moreover, in contrast to ATP, classical inducers of cell apoptosis such as FasL or anti-Fas antibody are relatively ineffective at reducing intracellular BCG viability within infected human macrophages [6, 21]. In addition, using a lower dose of ATP (3 mM), a lower MOI (5:1) and a lower duration of culture, we failed to observe any difference in apoptosis levels between ATP-treated and control cells, as revealed by flow cytometric determination of active caspase-3 expression (data not shown). Though it is probable that macrophage apoptosis plays a role in ATP-mediated mycobacterial killing, the rapid decline in intracellular BCG viability immediately after ATP exposure appears to be primarily mediated by autophagy. This is consistent with our observation that wortmannin, a classical inhibitor of autophagy, achieved only partial reversal of bactericidal activity while the P2X7-antagonist, oATP, almost completely inhibited ATP-induced bacterial killing (Figure 4). Similarly, in our confocal studies neither anti-P2X7 or wortmannin treatment completely ablated the co-localisation observed following ATP stimulation (Figure 2B &2C), implying that other mechanisms are involved in mediating this effect. The results suggest that ATP-induced mycobactericidal activity is dependent on both autophagy as well as apoptosis. The use of a more specific P2X7 inhibitor such as KN62 or combinations of inhibitors such as anti-P2X7 and wortmannin, which may exhibit synergistic activity may help to clarify the relative roles of each process. That autophagy is involved in ATP-mediated mycobactericidal activity is supported by previous reports describing profound changes in the architecture of the intracellular vacuolar system of ATP-treated infected macrophages [, our unpublished observations]. However, these changes were also accompanied by membrane blebbing and nuclear condensation (results not shown), which are morphological changes associated with early stages of apoptosis supporting a role for both processes in the associated mycobactericidal effect. Multiple, large cytosolic vacuoles were also formed within non-BCG infected cells following ATP treatment (Figure 3B). Although no detailed assessment was made of their structure in terms of whether they represented autophagosome formation, it was noted that cellular debris was apparent in a high percentage of them. Our laboratory is currently undertaking a detailed assessment of such structures to determine the degree of autophagosome formation within ATP-treated macrophages.
That autophagy may prove a critical mycobactericidal effector mechanism utilized by phagocytes is also suggested by the fact that we have previously reported, using macrophages derived from p47Phox-/- and iNOS-/- mice, that neither oxygen or nitrogen radical generation are involved in mediating ATP-induced, mycobactericidal activity . Moreover, parallel studies performed in BCG-infected macrophages, derived from both NRAMP resistant and susceptible strains of mice, also failed to reveal any influence of this additional macrophage-associated, anti-bacterial mechanism on the mycobactericidal effects of ATP . Thus many of the classical, cell-mediated, antibacterial effector mechanisms of oxygen and nitrogen radical generation, or Nramp protein expression do not appear to be involved in, and hence as effective as induction of autophagy in the ATP-mediated killing of intracellular mycobacteria.
Work is currently underway in our laboratory to further analyze the relative roles played by autophagy and apoptosis and their inter-dependence in the mycobactericidal activity mediated by ATP.
We report that exposure to ATP induces human monocytes/macrophages to undergo rapid cell autophagy, through a P2X7-dependent mechanism. Induction of autophagy is associated with augmented mycobactericidal activity of macrophages, which is mediated through increased phago-lysosomal fusion of mycobacterial phagosomes. These results support the importance of autophagy as an innate, cellular, mycobactericidal mechanism and highlight a potential therapeutic role for P2X7 agonists in the treatment of MDR-TB.
ATP, bzATP, oATP, UTP, wortmannin, ethylene glycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic acid (EGTA) and calcium chloride (CaCl2) were purchased from Sigma (Poole, UK). The rabbit anti-LC3 polyclonal antibody and anti-rabbit secondary antibody were obtained from Novus Biologicals and Pierce Biotechnology respectively. The anti-P2X7 antibody was a kind gift from Dr Gary Buell (Geneva Biomedical Research Institute). Lysotracker Red was purchased from Cambrex Biosciences.
Cells and bacteria
Peripheral blood mononuclear cells (PBMC) were isolated from EDTA blood taken from healthy individuals by standard Ficoll-Hypaque (GE Healthcare Biosciences) gradient separation. Monocytes were then isolated from the PBMC by overnight adherence to 75 ml plastic tissue culture flasks (Corning), washed thrice to remove any non-adherent cells and resuspended by chilling on ice for 30 mins and pipetting with pre-chilled (4°C) PBS. The monocytes were washed and re-suspended (2.5 × 106 cells/ml) in RPMI 1640 medium (Life Technologies, Paisley, U.K.) containing 5% pooled AB+ male human serum (First Link, West Midlands, U.K.), 2 mM L-glutamine (Life Technologies) (complete medium) and rh-GM-CSF (90 IU/ml) (Berlex USA).
THP-1 cells were obtained from the American Type Culture Collection (Manassas, VA) and cultured in RPMI 1640 medium + 10% fetal calf serum + 2 mM L-glutamine. The cells were used in a non-activated/differentiated state to maintain their early monocytic phenotype.
For experiments using calcium-free media, the cells were grown in standard Hank's Balanced Salt Solution (HBSS) or in calcium free HBSS + 2 mM EGTA. The latter was added to chelate any residual Ca2+.
Stock cultures of M bovis-BCG (Evans strain) were maintained in log phase growth in Middlebrook 7H9 broth (Difco, Detroit, MI) supplemented with 10% Middlebrook ADC enrichment media (Difco) and 0.02% Tween (Difco) at 37°C. The concentration of the BCG stock was determined by direct counting using a Thoma counting chamber (Weber Scientific UK) under dark ground illumination.
GFP-BCG was obtained as a kind gift from Prof D. Young (Imperial College of London, London, U.K). The BCG contained the gene encoding a FACS-optimized GFP protein  constitutively expressed under the control of the mycobacterial heat shock protein 60 promoter in a pSMT3 shuttle vector construct . Stock aliquots, stored in glycerol at -70°C, were grown to log phase in 7H9 broth supplemented with 10% ADC enrichment medium, 0.2% Tween 80, and 50 μg/ml hygromycin (Sigma, St. Louis, MO).
Western blot assay
Following exposure for 30 min to 3 mM ATP, THP1 cells and blood-derived monocytes were washed once in PBS and resuspended in RIPA buffer + protease inhibitor (Sigma, St. Louis, MO) and the cell lysate stored at -80°C prior to assay. SDS-PAGE was performed using a 15% discontinuous gel at 120 V. Following electrophoresis the resolved proteins were transferred onto a PVDF membrane at 80 V for 60 minutes, using a Biorad transfer apparatus. The blot was removed from the transfer apparatus and blocked overnight at 4°C in TBS-T, containing 5% nonfat dried milk. The blot was washed thrice in TBS-T following overnight incubation and then probed with a rabbit polyclonal anti-LC3 antibody (diluted 1:1000 in TBS-T/milk) for 60 minutes. After 3 rinses in TBS-T, peroxidase-conjugated anti-rabbit secondary antibody was applied for 1 hour and the excess antibody removed by washing thrice in TBS-T and the reaction developed using Supersignal West Pico ECL reagents.
In experiments incorporating purinergic receptor agonist and antagonists, oATP (0.3 mM) or anti-P2X7 antibody (3 μg/ml) were added to the cells for 2 hr/37°C and 1 hr/37°C respectively, prior to addition of ATP (3 mM) for 30 minutes/37°C. UTP (3 mM), and bzATP (3 mM) were similarly added to cells for 30 minutes/37°C before processing them for western blot analysis for LC3 protein expression.
Confocal fluorescent microscopy
MDMs were grown to sub-confluence on poly-L-lysine coated glass-bottom dishes (MatTek) at approximately 5 × 105 cells/dish for 5 days. GFP-BCG were then added to the macrophages at an MOI of 5:1 and incubated overnight. Following removal of extracellular bacteria by multiple washing, LysoTracker red (75 nM) was added to the cells for 1 hour at 37°C to stain lysosomes. Wortmannin (100 nM) and anti-P2X7 antibody (3 μg/ml) was then added for 1 hr at 37°C before addition of ATP (3 mM) in appropriate wells. Following exposure to ATP for 30 minutes, the cells were washed in RPMI. Cells were imaged live using a Zeiss LSM510 confocal microscope using excitation wavelengths of 488 and 546 nm to visualize GFP and Lysotracker Red respectively. For LC3 staining, MDMs were grown on poly-L-lysine coated glass coverslips for 5 days. Following treatment with ATP, cells were fixed with methanol at -20°C for 30 minutes. Cells were then washed with PBS and incubated in PBS containing 5% donkey serum to block non-specific binding. Cells were incubated with anti- LC3 antibody (1:500) for 1 hour, followed by three washes in PBS and treatment with anti-rabbit secondary antibody, conjugated with AlexaFluor 555 (Invitrogen), for 1 hour. Cells were washed 5 times in PBS and mounted onto slides with Vectashield (Vector Laboratories, CA) as a mounting medium. Fluorescence was visualized by confocal microscopy.
Cells were prepared for transmission electron microscopy (TEM) by pelleting the various cell preparations in 1.5 ml eppendorfs following centrifugation for 1 min/6000 rpm in an eppendorf (Hettich) centrifuge. The cell pellets were then fixed in freshly prepared gluteraldhyde fixative and stored at 4°C until ready for processing. TEM processing of the cell samples was performed at the EM microscopy suite, University of Birmingham according to standard fixation protocols.
BCG viability assay
Macrophages were grown to sub-confluence (approx 5 × 104cells/well) in 96-well round-bottom microtiter plates (Corning) at 200 μl/well. A total of 2.5 × 105 BCG per well was added (MOI 5:1) and incubated at 37°C/5%CO2 overnight. Excess BCG was removed by washing thrice in RPMI. Where appropriate, wortmannin (100 nM) and oATP (0.3 mM) were added 1 and 2 hr respectively prior to addition of ATP (3 mM). Intracellular BCG viability following exposure of infected cells to ATP for 30 min, was assessed by 3H-uridine incorporation assay as this provided a much more rapid assessment (within 72 hrs) of the mycobacterstatic effect of ATP as compared to colony forming unit (CFU) assay assessment which takes > 14 days to form countable colonies. The BCG-infected cells were washed and cultured in RPMI +5%AB+ serum and at appropriate time points, a total of 150 μl cell supernatant was removed and transferred to a separate 96 well plate. Cell lysis was performed on the remaining cell pellets by addition of 50 ul of a 0.2% saponin solution for 30 min/37°C. After 30 min, 100 μl of Middlebrook 7H9 (+10% ADC supplement) was added to each well of both the cell supernatant and pellet lysates followed by addition of 20 μl/well of a 100 μCi/ml stock of 3H-uridine (Amersham UK). The wells were harvested after 72 hours on a '1205 betaplate scintillation counter' (Wallac) and the combined counts/min of the matched cell supernatant and pellet wells were taken as an indicator of relative bacterial viability.
The Student's t-test was used for all statistical comparisons.
We would like to thank Prof D. Young and Dr Gary Buell for kindly providing the GFP-labeled BCG and the anti-P2X7 antibodies respectively.
- WHO TB Factsheets. [http://www.who.int/mediacentre/factsheets/fs104/en/index.html]
- Nakagawa I, Amano A, Mizushima N, Yamamoto A, Yamaguchi H, Kamimoto T, Nara A, Funao J, Nakata M, Tsuda K, Hamada S, Yoshimori T: Autophagy defends cells against invading group A Streptococcus. Science. 2004, 306: 1037-1040. 10.1126/science.1103966.View ArticlePubMedGoogle Scholar
- Ogawa M, Yoshimori T, Suzuki T, Sagara H, Mizushima N, Sasakawa C: Escape of intracellular Shigella from autophagy. Science. 2005, 307: 727-731. 10.1126/science.1106036.View ArticlePubMedGoogle Scholar
- Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V: Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell. 2004, 119: 753-766. 10.1016/j.cell.2004.11.038.View ArticlePubMedGoogle Scholar
- Alonso S, Pethe K, Russell DG, Purdy GE: Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy. Proc Natl Acad Sci USA. 2007, 104: 6031-6036. 10.1073/pnas.0700036104.PubMed CentralView ArticlePubMedGoogle Scholar
- Lammas DA, Stober C, Harvey CJ, Kendrick N, Panchalingam S, Kumararatne DS: ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity. 1997, 7: 433-444. 10.1016/S1074-7613(00)80364-7.View ArticlePubMedGoogle Scholar
- Stober CB, Lammas DA, Li CM, Kumararatne DS, Lightman SL, McArdle CA: ATP-mediated killing of Mycobacterium bovis bacille Calmette-Guérin within human macrophages is calcium dependent and associated with the acidification of mycobacteria-containing phagosomes. J Immunol. 2001, 166: 6276-6286.View ArticlePubMedGoogle Scholar
- Fernando SL, Saunders BM, Sluyter R, Skarratt KK, Goldberg H, Marks GB, Wiley JS, Britton WJ: A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis. Am J Respir Crit Care Med. 2007, 175: 360-366. 10.1164/rccm.200607-970OC.View ArticlePubMedGoogle Scholar
- Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori T: LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000, 19: 5720-5728. 10.1093/emboj/19.21.5720.PubMed CentralView ArticlePubMedGoogle Scholar
- Deretic V: Autophagy as an immune defense mechanism. Curr Opin Immunol. 2006, 18: 375-382. 10.1016/j.coi.2006.05.019.View ArticlePubMedGoogle Scholar
- Via LE, Fratti RA, McFalone M, Pagan-Ramos E, Deretic D, Deretic V: Effects of cytokines on mycobacterial phagosome maturation. J Cell Sci. 1998, 111: 897-905.PubMedGoogle Scholar
- Birmingham CL, Canadien V, Gouin E, Troy EB, Yoshimori T, Cossart P, Higgins DE, Brumell JH: Listeria monocytogenes evades killing by autophagy during colonization of host cells. Autophagy. 2007, 3: 442-451.View ArticlePubMedGoogle Scholar
- Schnaith A, Kashkar H, Leggio SA, Addicks K, Krönke M, Krut O: Staphylococcus aureus subvert autophagy for induction of caspase-independent host cell death. J Biol Chem. 2007, 282: 2695-2706. 10.1074/jbc.M609784200.View ArticlePubMedGoogle Scholar
- Schellens JP, Vreeling-Sindelárová H, Plomp PJ, Meijer AJ: Hepatic autophagy and intracellular ATP. A morphometric study. Exp Cell Res. 1988, 177: 103-108. 10.1016/0014-4827(88)90028-6.View ArticlePubMedGoogle Scholar
- Worthington RA, Smart ML, Gu BJ, Williams DA, Petrou S, Wiley JS, Barden JA: Point mutations confer loss of ATP-induced human P2X(7) receptor function. FEBS Lett. 2002, 512: 43-46. 10.1016/S0014-5793(01)03311-7.View ArticlePubMedGoogle Scholar
- Shemon AN, Sluyter R, Fernando SL, Clarke AL, Dao-Ung LP, Skarratt KK, Saunders BM, Tan KS, Gu BJ, Fuller SJ, Britton WJ, Petrou S, Wiley JS: A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages. J Biol Chem. 2006, 281: 2079-2086. 10.1074/jbc.M507816200.View ArticlePubMedGoogle Scholar
- Molloy A, Laochumroonvorapong P, Kaplan G: Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin. J Exp Med. 1994, 180: 1499-1509. 10.1084/jem.180.4.1499.View ArticlePubMedGoogle Scholar
- Smith RA, Alvarez AJ, Estes DM: The P2X7 purinergic receptor on bovine macrophages mediates mycobacterial death. Vet Immun & Immunopath. 2001, 78: 249-262. 10.1016/S0165-2427(01)00245-8.View ArticleGoogle Scholar
- Placido R, Auricchio G, Falzoni S, Battistini L, Colizzi V, Brunetti E, Di Virgilio F, Mancino G: P2X(7) purinergic receptors and extracellular ATP mediate apoptosis of human monocytes/macrophages infected with Mycobacterium tuberculosis reducing the intracellular bacterial viability. Cell Immun. 2006, 244: 10-18. 10.1016/j.cellimm.2007.02.001.View ArticleGoogle Scholar
- Stober CB, Ben-Smith A, Kumararatne D, Lammas DA: Characterisation of the P2X7 receptor-mediated signaling pathway associated with rapid killing of intracellular mycobacteria within human macrophages. Drug Dev Res. 2001, 53: 105-116. 10.1002/ddr.1177.View ArticleGoogle Scholar
- Fairbairn IP: Investigations of a novel mechanism of antituberculous immunity mediated by purinergic (P2X7) receptors. PhD thesis. 2001, University of Birmingham UK, Chapter 4: 58-64.Google Scholar
- Fairbairn IP, Stober CB, Kumararatne DS, Lammas DA: ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X(7)-dependent process inducing bacterial death by phagosome-lysosome fusion. J Immunol. 2001, 167: 3300-3307.View ArticlePubMedGoogle Scholar
- Cormack BP, Valdivia RH, Falkow S: FACS-optimized mutants of the green fluorescent protein (GFP). Gene. 1996, 173: 33-38. 10.1016/0378-1119(95)00685-0.View ArticlePubMedGoogle Scholar
- Snewin VA, Gares MP, Gaora PO, Hasan Z, Brown IN, Young DB: Assessment of immunity to mycobacterial infection with luciferase reporter constructs. Infect Immun. 1999, 67: 4586-4593.PubMed CentralPubMedGoogle Scholar
- Kusner DJ, Barton JA: ATP stimulates human macrophages to kill intracellular virulent Mycobacterium tuberculosis via calcium-dependent phagosome-lysosome fusion. J Immunol. 2001, 167: 3308-3315.View ArticlePubMedGoogle Scholar
- Reaves BJ, Bright NA, Mullock BM, Luzio JP: The effect of wortmannin on the localization of lysosomal type 1 intergral membrane glycoproteins suggests a role for phospoinositide 3-kinase activity in regulating membrane traffic late in the endocytic pathway. J Cell Science. 1996, 109: 749-763.PubMedGoogle Scholar
- Bright NA, Reaves BJ, Mullock BM, Luzio JP: Dense core lysosomes can fuse with late endosomes and are re-formed from the resultant hybrid organelles. 1997, 110: 2027-2040.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.